Activation of the STING pathway in the tumor microenvironment by antigen-presenting cells results in the generation of IFN-I and facilitates the spontaneous development of CD8+ T-cell responses against tumors, which exhibited therapeutic effects in multiple murine cancer models (67, 68). Here, STING1 is linked to cancer.